% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • theman111knows theman111knows Nov 21, 2012 3:58 PM Flag

    Piper jaffary " SRPT NEAR TERM $60-$80. AFTER APPROVAL $160" link

    Street Insider
    Sarepta Therapeutics (SRPT) Jumps on Bullish Comments
    November 21, 2012 9:18 AM EST
    Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is seeing strong pre-open action following positive comments from analysts at Piper Jaffray. The firm said it has the potential to be a $160/share stock but a nearer-term range could be $60-$80/share.

2.12+0.04(+1.92%)Nov 24 4:00 PMEST